Analysts’ Viewpoint on Healthcare Contract Research Outsourcing Market Scenario
The healthcare contract research outsourcing market is projected to witness strong growth during the forecast period driven by increase in funding for small to mid-sized pharmaceutical, biotechnology, and medical device companies, thus driving the companies to opt for CRO services with focus on niche markets. The global healthcare contract research outsourcing market is witnessing high growth, owing to globalization of clinical trials, increasing efforts for optimization of costs and development time for drug development, and rise in varied services and solutions offered by the CROs. Increased access to specialized technologies and therapeutics expertise is projected to fuel the adoption of clinical trial services in the North America during the forecast period.
The global healthcare contract research outsourcing market is expected to expand on the back of several factors including surge in efforts intended for costs & drug development time optimization, increase in different services and solutions provided by the CROs, and globalization of clinical trials. Some of the important services available in the healthcare contract research outsourcing market include regulatory service, clinical trial service, pharmacovigilance, site management protocol, and medical writing. These services are mainly used by biotechnology companies, pharmaceutical companies, academic institutes & government organizations, and medical device companies across the globe.
Enterprises from the global healthcare contract research outsourcing market are estimated to observe increase in demand for regulatory services outsourcing. This increase can be attributed to rise in scrutiny by regulatory authorities, including the EMA and FDA at all stages of clinical trials. Moreover, changing regulatory needs in each region is expected to drive the demand opportunities for regulatory services outsourcing activities.
Companies in the healthcare contract research outsourcing market are entering into collaboration and acquisition agreements in order to maintain their leading market position and expand their presence in newer regions. Some of the key players operating in the global healthcare contract research outsourcing market are focusing on offering quality services to gain attention from consumers. Outsourcing improves the global reach with respect to drug development with minimum maintenance cost, as CROs are well-versed with regulatory requirements of various regions to fueling the expansion of healthcare contract research outsourcing market. Healthcare companies often outsource drug development functions to contract research organizations to efficiently and effectively use the development capabilities internationally.
North America is expected to offer lucrative opportunities due to factors such as presence of advanced infrastructure required for clinical researches and key government incentive programs in the region, specifically in the U.S. In addition, increase in availability of therapeutics expertise and specialized technologies is expected to result in rise in the number of clinical trial services in the U.S. in the upcoming years. The North America healthcare contract research outsourcing market is rising with increasing complex regulatory process & growing regulatory burden. The market in North America is primarily driven by advanced infrastructure of clinical research sites, and effective government incentive programs in United States. The Asia Pacific region is projected to be fastest growing region in the global healthcare contract research outsourcing market during the forecast period. In Asia Pacific, China and India are significant markets for healthcare CRO and India is estimated to grow at a rapid pace during the forecast period.
The clinical, therapeutic, and regulatory expertise of CROs help to improve the complete cost of development and accelerate time to market a new product. CROs have become larger and enormously more diversified across various therapeutic areas and functions, expanding their penetration. Small pharmaceutical companies are also looking for advancements in product development through CRO services due to rise in demand for innovative products and patent expiration. CROs are anticipated to expand geographically and add competencies in emerging therapeutic areas, while boosting their current services beyond traditional clinical capabilities, including post-approval, commercial, informatics, etc. where low - outsourced penetration observed, further enhancing the demand for CROs, driving greater outsourcing demand. The regulatory services outsourcing is anticipated to increase due to increased scrutiny by regulatory bodies such as the FDA and EMA at every stage of clinical trial and changing regulatory requirements as per the region.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 38.04 Bn |
|
Market Forecast Value in 2028 |
US$ 63.09 Bn |
|
Growth Rate (CAGR) |
6.6% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Healthcare Contract Research Outsourcing Market – Segmentation
TMR’s study on the global healthcare contract research outsourcing market includes information divided into four segments: service, therapeutic area, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global healthcare contract research outsourcing market are discussed in detail.
| Service |
|
| Therapeutic Area |
|
| End-User |
|
| Region |
|
Healthcare contract research outsourcing market to surpass the value of US$ 63.09 by 2028
Healthcare contract research outsourcing market is projected to witness CAGR of over 6.6% from 2021 to 2028
Healthcare contract research outsourcing market is driven by increase in different services and solutions provided by the CROs
Asia Pacific region is projected to be fastest growing region in global healthcare contract research outsourcing market during the forecast period
Key players in the global healthcare contract research outsourcing market include Syneos Health, IQVIA, PRA Health Sciences, Inc., ICON PLC, and Laboratory Corporation of America Holdings
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Healthcare Contract Research Outsourcing Market
4. Market Overview
4.1. Introduction
4.1.1. Service Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Regulatory Scenario by Region/globally
5.3. COVID-19 Impact Analysis
6. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Service
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Service, 2017–2028
6.3.1. Clinical Trial Services
6.3.2. Regulatory Services
6.3.3. Clinical Data Management & Biometrics
6.3.4. Medical Writing
6.3.5. Pharmacovigilance
6.3.6. Site Management Protocol
6.3.7. Others
6.4. Market Attractiveness Analysis, by Service
7. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by End-user, 2017–2028
7.3.1. Pharmaceutical Companies
7.3.2. Biotechnology Companies
7.3.3. Medical Devices
7.3.4. Academic Institutes & Government Organizations
7.4. Market Attractiveness Analysis, by End-user
8. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Therapeutic Area
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
8.3.1. Oncology/Hematology
8.3.2. CNS
8.3.3. CV/Metabolic
8.3.4. Respiratory
8.3.5. Infectious Diseases
8.3.6. Immunology
8.3.7. Rare Diseases
8.3.8. Medical Devices
8.3.9. Others
8.4. Market Attractiveness Analysis, by Therapeutic Area
9. Global Healthcare Contract Research Outsourcing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Healthcare Contract Research Outsourcing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Service, 2017–2028
10.2.1. Clinical Trial Services
10.2.2. Regulatory Services
10.2.3. Clinical Data Management & Biometrics
10.2.4. Medical Writing
10.2.5. Pharmacovigilance
10.2.6. Site Management Protocol
10.2.7. Others
10.3. Market Value & Volume Forecast, by End-user, 2017–2028
10.3.1. Pharmaceutical Companies
10.3.2. Biotechnology Companies
10.3.3. Medical Devices
10.3.4. Academic Institutes & Government Organizations
10.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
10.4.1. Oncology/Hematology
10.4.2. CNS
10.4.3. CV/Metabolic
10.4.4. Respiratory
10.4.5. Infectious Diseases
10.4.6. Immunology
10.4.7. Rare Diseases
10.4.8. Medical Devices
10.4.9. Others
10.5. Market Value & Volume Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Service
10.6.2. By End-user
10.6.3. By Therapeutic Area
10.6.4. By Country
11. Europe Healthcare Contract Research Outsourcing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Service, 2017–2028
11.2.1. Clinical Trial Services
11.2.2. Regulatory Services
11.2.3. Clinical Data Management & Biometrics
11.2.4. Medical Writing
11.2.5. Pharmacovigilance
11.2.6. Site Management Protocol
11.2.7. Others
11.3. Market Value & Volume Forecast, by End-user, 2017–2028
11.3.1. Pharmaceutical Companies
11.3.2. Biotechnology Companies
11.3.3. Medical Devices
11.3.4. Academic Institutes & Government Organizations
11.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
11.4.1. Oncology/Hematology
11.4.2. CNS
11.4.3. CV/Metabolic
11.4.4. Respiratory
11.4.5. Infectious Diseases
11.4.6. Immunology
11.4.7. Rare Diseases
11.4.8. Medical Devices
11.4.9. Others
11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Service
11.6.2. By End-user
11.6.3. By Therapeutic Area
11.6.4. By Country/Sub-region
12. Asia Pacific Healthcare Contract Research Outsourcing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Service, 2017–2028
12.2.1. Clinical Trial Services
12.2.2. Regulatory Services
12.2.3. Clinical Data Management & Biometrics
12.2.4. Medical Writing
12.2.5. Pharmacovigilance
12.2.6. Site Management Protocol
12.2.7. Others
12.3. Market Value & Volume Forecast, by End-user, 2017–2028
12.3.1. Pharmaceutical Companies
12.3.2. Biotechnology Companies
12.3.3. Medical Devices
12.3.4. Academic Institutes & Government Organizations
12.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
12.4.1. Oncology/Hematology
12.4.2. CNS
12.4.3. CV/Metabolic
12.4.4. Respiratory
12.4.5. Infectious Diseases
12.4.6. Immunology
12.4.7. Rare Diseases
12.4.8. Medical Devices
12.4.9. Others
12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Service
12.6.2. By End-user
12.6.3. By Therapeutic Area
12.6.4. By Country/Sub-region
13. Latin America Healthcare Contract Research Outsourcing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Service, 2017–2028
13.2.1. Clinical Trial Services
13.2.2. Regulatory Services
13.2.3. Clinical Data Management & Biometrics
13.2.4. Medical Writing
13.2.5. Pharmacovigilance
13.2.6. Site Management Protocol
13.2.7. Others
13.3. Market Value & Volume Forecast, by End-user, 2017–2028
13.3.1. Pharmaceutical Companies
13.3.2. Biotechnology Companies
13.3.3. Medical Devices
13.3.4. Academic Institutes & Government Organizations
13.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
13.4.1. Oncology/Hematology
13.4.2. CNS
13.4.3. CV/Metabolic
13.4.4. Respiratory
13.4.5. Infectious Diseases
13.4.6. Immunology
13.4.7. Rare Diseases
13.4.8. Medical Devices
13.4.9. Others
13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Service
13.6.2. By End-user
13.6.3. By Therapeutic Area
13.6.4. By Country/Sub-region
14. Middle East & Africa Healthcare Contract Research Outsourcing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Service, 2017–2028
14.2.1. Clinical Trial Services
14.2.2. Regulatory Services
14.2.3. Clinical Data Management & Biometrics
14.2.4. Medical Writing
14.2.5. Pharmacovigilance
14.2.6. Site Management Protocol
14.2.7. Others
14.3. Market Value & Volume Forecast, by End-user, 2017–2028
14.3.1. Pharmaceutical Companies
14.3.2. Biotechnology Companies
14.3.3. Medical Devices
14.3.4. Academic Institutes & Government Organizations
14.4. Market Value & Volume Forecast, by Therapeutic Area, 2017–2028
14.4.1. Oncology/Hematology
14.4.2. CNS
14.4.3. CV/Metabolic
14.4.4. Respiratory
14.4.5. Infectious Diseases
14.4.6. Immunology
14.4.7. Rare Diseases
14.4.8. Medical Devices
14.4.9. Others
14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Service
14.6.2. By End-user
14.6.3. By Therapeutic Area
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Syneos Health
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. PAREXEL International
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. ICON plc
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. PRA Health Sciences, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Charles River
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Laboratory Corporation of America Holdings (Covance)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. IQVIA
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Medpace
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Pharmaceutical Product Development, LLC.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
List of Table
Table 01: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028
Table 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028
Table 03: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2028
Table 04: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
Table 05: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 06: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Region, 2017–2028
Table 07: North America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country, 2017–2028
Table 08: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028
Table 09: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Service, 2017–2028
Table 10: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2028
Table 11: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
Table 12: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 13: Europe Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2028
Table 14: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Services, 2017–2028
Table 15: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028
Table 16: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028
Table 17: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
Table 18: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 19: Asia Pacific Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 20: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028
Table 21: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028
Table 22: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028
Table 23: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
Table 24: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 25: Latin America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 26: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028
Table 27: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028
Table 28: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028
Table 29: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
Table 30: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 31: Middle East & Africa Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 32: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2028
Table 33: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2028
Table 34: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2028
Table 35: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2028
Table 36: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2028
List of Figures
Figure 01: Healthcare Contract Research Outsourcing Market Snapshot
Figure 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028
Figure 03: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2020
Figure 04: Global Healthcare Contract Research Outsourcing Market Value Share, by Region, 2020
Figure 05: Global Healthcare Contract Research Outsourcing Market Value Share, by Service, 2020
Figure 06: Global Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020
Figure 07: Global Healthcare Contract Research Outsourcing Market Value Share, by Service, 2017 and 2028
Figure 08: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Trial Services, 2017–2028
Figure 09: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Regulatory Services, 2017–2028
Figure 10: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Clinical Data Management & Biometrics, 2017–2028
Figure 11: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Writing, 2017–2028
Figure 12: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmacovigilance, 2017–2028
Figure 13: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Site Management Protocol, 2017–2028
Figure 14: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service
Figure 15: Global Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2017 and 2028
Figure 16: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Oncology, 2017–2028
Figure 17: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CNS, 2017–2028
Figure 18: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by CV/Metabolic, 2017–2028
Figure 19: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Respiratory, 2017–2028
Figure 20: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Infectious Diseases, 2017–2028
Figure 21: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Immunology, 2017–2028
Figure 22: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Rare Diseases, 2017–2028
Figure 23: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Devices, 2017–2028
Figure 24: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area
Figure 25: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by End-user, 2017 and 2028
Figure 26: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017–2028
Figure 27: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Biotechnology Companies, 2017–2028
Figure 28: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Medical Device Companies, 2017–2028
Figure 29: Global Healthcare Contract Research Outsourcing Market Revenue (US$ Mn), by Academic Institute & Government Organizations Companies, 2017–2028
Figure 30: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028
Figure 31: Global Healthcare Contract Research Outsourcing Market Value Share Analysis, by Region, 2021 and 2028
Figure 32: Global Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Region, 2021–2028
Figure 33: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028
Figure 34: North America Healthcare Contract Research Outsourcing Market Value Share, by Country, 2020 and 2028
Figure 35: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country, 2021-2020
Figure 36: North America Healthcare Contract Research Outsourcing Market Value Share, by Services, 2020 and 2028
Figure 37: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services, 2020-1028
Figure 38: North America Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028
Figure 39: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028
Figure 40: North America Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
Figure 41: North America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028
Figure 42: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2021–2028
Figure 43: Europe Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028
Figure 44: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 45: Europe Healthcare Contract Research Outsourcing Market Value Share, by Services, 2020 and 2028
Figure 46: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Services, 2021–2028
Figure 47: Europe Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2020 and 2028
Figure 48: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028
Figure 49: Europe Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
Figure 50: Europe Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028
Figure 51: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028
Figure 52: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028
Figure 53: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 54: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Service, 2021 and 2028
Figure 55: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021-2028
Figure 56: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028
Figure 57: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028
Figure 58: Asia Pacific Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
Figure 59: Asia Pacific Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028
Figure 60: Latin America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028
Figure 61: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Service, 2020 and 2028
Figure 62: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021–2028
Figure 63: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area 2020 and 2028
Figure 64: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028
Figure 65: Latin America Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
Figure 66: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028
Figure 67: Latin America Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028
Figure 68: Latin America Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 69: Middle East & Africa Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, 2017–2028
Figure 70: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Country/Sub-region, 2020 and 2028
Figure 71: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
Figure 72: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Service, 2021 and 2028
Figure 73: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Service, 2021-2028
Figure 74: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by Therapeutic Area, 2021-2028
Figure 75: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2021–2028
Figure 76: Middle East & Africa Healthcare Contract Research Outsourcing Market Value Share, by End-user, 2020 and 2028
Figure 77: Middle East & Africa Healthcare Contract Research Outsourcing Market Attractiveness Analysis, by End-user, 2021–2028
Figure 78: Global Healthcare Contract Research Outsourcing Market Share Analysis, by Company, 2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Healthcare Contract Research Outsourcing Market
